Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

BACKGROUND: Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of antiangiogenic-based treatment and systemic inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Lago, Nieves, Fernández-Montes, Ana, Covela, Marta, Brozos, Elena M., De la Cámara, Juan, Méndez Méndez, José C., Jorge-Fernández, Mónica, Cousillas Castiñeiras, Antía, Reboredo, Cristina, Arias Ron, David, Pellón Augusto, María L., González Villarroel, Paula, Graña, Begoña, Salgado Fernández, Mercedes, Carral Maseda, Alberto, Vázquez Rivera, Francisca, Candamio Folgar, Sonia, Reboredo López, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807898/
https://www.ncbi.nlm.nih.gov/pubmed/33446148
http://dx.doi.org/10.1186/s12885-020-07758-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807898/
https://www.ncbi.nlm.nih.gov/pubmed/33446148
http://dx.doi.org/10.1186/s12885-020-07758-5

Ejemplares similares